Ayrton Capital LLC 13D/13G Filings for ReShape Lifesciences Inc. (RSLS)

Ayrton Capital LLC 13D and 13G filings for ReShape Lifesciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-13
06:32 am
Sale
2025-06-3013GRESHAPE LIFESCIENCES INC C
RSLS
Ayrton Capital LLC20
0.000%
-49,980decrease
(-99.96%)
Filing